Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Dri Healthcare Trust (DHT-UN.TO)

Dri Healthcare Trust (DHT-UN.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Dri Healthcare Trust 100 King Street West 1 First Canadian Place, Suite 7250 Toronto ON M5X 1B1 CAN

https://www.dricapital.com P: 416-863-1865 F: 416-863-5161

Sector:

Medical

Description:

DRI Healthcare Trust is engaged in pharmaceutical royalty monetization by providing capital to inventors, academic institutions, and biopharma companies. Trust was formed to provide Unitholders with differential exposure to the pharmaceutical and biotechnology industries through ownership and acquisitions of pharmaceutical royalties. In return for providing capital to biopharmaceutical innovators, the company is building a diversified portfolio of interests in medicines that have a demonstrable positive impact on the world. The Trust has concluded that it operates as one segment, focused on acquiring royalty assets. Geographically the trust generates it's key revenue from the United States. The trust also generates Income from markets such as Japan, and the European Union.

Key Statistics

Overview:

Market Capitalization, $K 929,655
Shares Outstanding, K 55,096
Annual Sales, $ 139,679 K
Annual Net Income, $ -3,364 K
Last Quarter Sales, $ 38,908 K
Last Quarter Net Income, $ -57,860 K
60-Month Beta 0.16
% of Institutional Shareholders 1.02%

Growth:

1-Year Return 35.05%
3-Year Return 109.27%
5-Year Return 0.00%

Per-Share Information:

Most Recent Earnings -1.05 on 11/05/25
Next Earnings Date N/A
Earnings Per Share ttm -0.94
Annual Dividend & Yield 0.39 (3.43%)
Annual Dividend & Yield (Fwd) 0.40 (3.43%)
Most Recent Dividend 0.100 on 12/31/25
Next Ex-Dividends Date 12/31/25
Dividend Payable Date 01/20/26
Dividend Payout Ratio 0.00%

DHT-UN.TO Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward 45.66
Price/Earnings to Growth N/A
Return-on-Equity % -10.87%
Return-on-Assets % -5.83%
Profit Margin % -2.41%
Debt/Equity 0.61
Price/Sales 4.52
Price/Book 1.50
Book Value/Share 10.93

DHT-UN.TO Dividends

Date Value
12/31/25 $0.1000
09/29/25 $0.1000
06/30/25 $0.1000
03/31/25 $0.1000
12/31/24 $0.0850
09/27/24 $0.0850
06/28/24 $0.0850
03/27/24 $0.0850
12/28/23 $0.2662
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar